Table 2

MUC1 expression in endocervical and endometrial adenocarcinomas

Median (range)

+ Cases/Total (%)1


ECA

EMMA

(p-value)

ECA

EMMA

(p-value)


Apical

35 (0–100)

15 (0–90)

NS

8/14 (57%)

7/18 (39%)

NS

A/C

0 (0–80)

70 (0–100)

<0.001

2/14 (14%)

14/18 (78%)

<0.001

Negative

35 (0–100)

0 (0–90)

0.01

7/14 (50%)

2/18 (11%)

0.01


ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma; A/C, apical/cytoplasmic; NS, not significant. 1 totals are >100% because different areas of tumors differed in staining pattern.

Khoury et al. BMC Clinical Pathology 2006 6:1   doi:10.1186/1472-6890-6-1

Open Data